InfuSystem Holdings, Inc. (INFU)
| Market Cap | 197.39M |
| Revenue (ttm) | 104.68M |
| Net Income (ttm) | 391,000 |
| Shares Out | 20.54M |
| EPS (ttm) | 0.01 |
| PE Ratio | 800.83 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,980,372 |
| Open | 8.90 |
| Previous Close | 8.86 |
| Day's Range | 8.90 - 9.78 |
| 52-Week Range | 6.78 - 21.89 |
| Beta | 1.21 |
| Analysts | Buy |
| Price Target | 22.10 (+130.0%) |
| Earnings Date | Aug 11, 2022 |
About INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company a... [Read more...]
Financial Performance
In 2021, INFU's revenue was $102.38 million, an increase of 5.13% compared to the previous year's $97.39 million. Earnings were $1.42 million, a decrease of -91.81%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for INFU stock is "Buy." The 12-month stock price forecast is 22.1, which is an increase of 129.97% from the latest price.
News
InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management
InfuSystem to Participate at Craig-Hallum 19th Annual Institutional Investor Conference on Wednesday, June 1, 2022
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at Craig-Hallum 19th Annual Institutional Investor Conference on Wednesday, June 1, 2022
InfuSystem Reports First Quarter 2022 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports First Quarter 2022 Financial Results
InfuSystem Announces Master Service Agreement with Leading Global Healthcare Technology and Diagnostic Company
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Master Service Agreement with Leading Global Healthcare Technology and Diagnostic Company
InfuSystem to Report First Quarter 2022 Financial Results on May 5, 2022
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2022 Financial Results on May 5, 2022
InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters
InfuSystem Inks Distribution Pact For Solo-Dex's Continuous Peripheral Nerve Block Catheters
InfuSystem Holdings Inc (NYSE: INFU) has announced a national distribution agreement with Solo-Dex Inc for its proprietary continuous nerve block catheters. With Solo-Dex catheter over the needle techno...
InfuSystem Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021
InfuSystem to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
InfuSystem to Present at Sidoti Winter Virtual Investor Conference on Wednesday, January 19, 2022
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Winter Virtual Investor Conference on Wednesday, January 19, 2022
InfuSystem Reports Third Quarter 2021 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem reports third quarter financial results, reaffirms 2021 guidance
Analysts Estimate InfuSystems Holdings, Inc. (INFU) to Report a Decline in Earnings: What to Look Out for
InfuSystems Holdings, Inc. (INFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InfuSystem to Report Third Quarter 2021 Financial Results on November 15, 2021
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to report third quarter 2021 financial results on November 15, 2021
InfuSystem Announces Pain Management Service Agreement with Leading U.S. Health Care Provider
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem has entered into exclusive 3-year pain management service agreement with a leading U.S. health care provider
InfuSystem to Participate in Lake Street's 5th Annual Best Ideas Growth (BIG5) Conference September 14, 2021
Rochester Hills, Michigan, Sept. 08, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitati...
3 Stock Picks With Growth Potential
Sealed Air, Trean Insurance Group and InfuSystems Holdings are trading close to or below their historical median valuations.
InfuSystems Holdings, Inc. (INFU) Misses Q2 Earnings and Revenue Estimates
InfuSystems Holdings, Inc. (INFU) delivered earnings and revenue surprises of -63.64% and -9.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
InfuSystem Reports Second Quarter 2021 Financial Results
Launched Fourth ITS Therapy - Lymphedema Announced $20 million Stock Repurchase Program Updates Guidance for 2021
InfuSystem to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
Strength Seen in InfuSystems Holdings, Inc. (INFU): Can Its 14.2% Jump Turn into More Strength?
InfuSystems Holdings, Inc. (INFU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further stre...
InfuSystem Announces $20 Million Stock Repurchase Program
ROCHESTER HILLS, Michigan, June 30, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitatin...
InfuSystem Enters Lymphedema Therapy Market
Providing pneumatic compression devices for last-mile patient care Providing pneumatic compression devices for last-mile patient care
InfuSystem to Participate at Craig-Hallum 18th Annual Institutional Investor Conference June 2, 2021
ROCHESTER HILLS, Michigan, May 27, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitatin...
InfuSystem Reports First Quarter 2021 Financial Results
Net Revenues: $24.5 million, a 14% increase Net Income: $0.7 million, a $1.1 million increase, Adjusted EBITDA: $6.2 million, a 51% increase, and Adjusted EBITDA margin of 25.2%, a 6.3% increase Com...
InfuSystem to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time